A 33 Year Old Moroccan Woman Dies Shortly after Receiving Johnson & Johnson’s Janssen COVID-19 Vaccine

A 33-year-old Moroccan woman from the city of Marrakech, received her dose of the Janssen (Johnson and Johnson) vaccine yesterday, Monday, July 26, 2021, at an official vaccination center (Bab Ighli). She died a few hours later, but the cause has not yet been determined.

Johnson & Johnson’s Janssen COVID-19 Vaccine

Johnson & Johnson’s Janssen COVID-19 Vaccine

The young woman worked at a hotel in the upper-class Agdal district and went with two colleagues of the same age to the Bab Ighli vaccination center.

Read Also: COVID-19: A Vaccine That Can Be Taken Orally as a Pill Is Being Tested in Israel

“At 10 a.m., a hotel shuttle came to take us away. All three of us were in good health. Our friend who died had anemia, but she had been completely cured of it for over a year. After we got the vaccine, we fainted trying to get into a cab and were taken back to the vaccination center to be taken care of but sadly our friend died before our eyes, on the spot, even before we could be rushed to the Mohammed VI Hospital,” one of the deceased woman’s colleagues said in a statement to local digital media.

Read Also: COVID-19: A Vaccine That Can Be Taken Orally as a Pill Is Being Tested in Israel

Morocco receives 300,000 doses of the Janssen vaccine this past Saturday and the country is just starting to vaccinate it’s 25- to 29-year-olds.

A source in the health ministry’s delegation in Marrakech, contacted by Le360 an online news website, said, “We cannot relate this death to vaccination,” before adding that an investigation has been launched to determine the circumstances of the death, without providing further details. Health secretary Khalid Aït Taleb’s health ministry has yet to officially comment on this sad incident.

In the Bab Ighli vaccination center, nearly 500 people received the vaccine from the American company Johnson & Johnson. On Saturday, July 24, Morocco received a batch of 300,000 doses of the Janssen vaccine under the Covax program. The health authorities decided to reserve them for areas where the virus is spreading at high rates, particularly Marrakech, Agadir, and Casablanca.

Read Also: Nightmare Scenario: Could the Current Poorly Implemented Vaccination Campaign Lead to More Deadly SARS-CoV-2 Strains

*Correction: The woman was 33 years old not 27



Related Articles:

Gilmore Health

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines

Guillain-Barré Syndrome Observed after the First Dose of the Astrazeneca Vaccine

How Many Antibodies Does It Take to Be Protected from the Virus after Vaccination?

COVID-19: Mixing AstraZeneca and Pfizer Vaccines is Safe and Effective Study Shows

Astrazeneca Vaccine: Could EDTA a Vaccine Preservative Be the Cause of Thrombosis?




Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.